Skip to main content
logo
Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.2650
0.00 (0.00%)
Sep 18, 2026, 3:59 PM EST

Pharmala Biotech Holdings Ratios and Metrics

Millions CAD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
29148194-
Market Cap Growth
147.68%84.59%-58.83%356.35%--
Enterprise Value
29137183-
Last Close Price
0.270.140.090.220.05-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
22.9323.777.5335.6053.16-
PB Ratio
15.065.863.9413.692.18-
P/TBV Ratio
148.9120.9261.41-6.24-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
EV/Sales Ratio
22.7321.717.0534.6737.77-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Debt / Equity Ratio
-0.13-0.39-0.21-0.14-0.45-0.93
Net Debt / EBITDA Ratio
0.180.490.730.290.984.28
Net Debt / FCF Ratio
0.260.921.310.571.369.35
Asset Turnover
0.380.190.390.220.03-
Inventory Turnover
0.540.150.620.65--
Quick Ratio
0.641.060.690.412.1318.28
Current Ratio
1.171.711.140.692.5618.28
Return on Equity (ROE)
-68.66%-98.00%-48.95%-47.41%-43.21%-
Return on Assets (ROA)
-26.50%-39.77%-13.58%-17.63%-21.48%-
Return on Capital Employed (ROCE)
-73.60%-81.80%-29.10%-48.40%-46.20%-21.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-5.53%-15.12%-10.56%-4.12%-23.75%-
FCF Yield
-3.34%-7.27%-4.12%-1.79%-15.14%-
Buyback Yield / Dilution
-8.69%-12.42%-4.79%-5.98%-163.82%-